The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients

NCT05485467 · clinicaltrials.gov ↗
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Medical Centre Ljubljana